| Do pregnancy rates differ with intra-uterine insemination when different combinations of semen analysis parameters are abnormal? | Michael H. DAHAN, Anita KURİYA, Chioma AGBO | 57–64 |
| Analyzing the etiology behind mortality associated with antepartum, intrapartum, and post-partum cases in a tertiary care teaching hospital of West Bengal | Md Illias Kanchan SK, Aparajita CHATTOPADHYAY, Ankit ANAND, Tapan Kumar NASKAR, Somajita CHAKRABORTY | 65–71 |
| Outcomes of robotic, laparoscopic, and open hysterectomy for benign conditions in obese patients | Ömer Lütfi TAPISIZ, İbrahim ALANBAY, Mostafa A. BORAHAY, Gökhan Sami KILIÇ | 72–77 |
| Independent predictors of survival in endometrium cancer: platelet-to-lymphocyte ratio and platelet/neutrophil/monocyte-to-lymphocyte ratio | İrem KAR, Taner TURAN, Seval YILMAZ ERGANİ, Alper KARALÖK, Günsu KİMYON CÖMERT, Osman TÜRKMEN, Selcan SİNANCI, Derman BAŞARAN | 78–86 |
| Does progesterone have protective effects on ovarian ischemia-reperfusion injury? | Ertan ADALI, Emine ÖZTÜRK, Banu GÜLEÇ BAŞER, Mine İslimye TAŞKIN, Adnan Adil HISMIOĞULLARI, Arzu YAY | 87–93 |
| Pregnancy in papillary thyroid cancer survivors | Hasan Tolga ÇELİK, Gökçen ÖRGÜL, M. Sinan BEKSAÇ, Fatih AKTOZ, Kemal BEKSAÇ, A. Seval ÖZGÜ ERDİNÇ | 94–97 |
| Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders | Belgin DEVRANOĞLU, Evrim BOSTANCI ERGEN, Çiğdem YAYLA ABİDE, Ahmet ESER | 98–103 |
| Current management of gynecologic cancer in pregnancy | Christos LAVAZZO, Evelyn Eleni MİNİS, Ioannis D. GKEGKES | 104–110 |
| Letter from a young female physician, Candidate | Esra BİLİR | 113–113 |
| Highlights and future directions from the European Gynecological Oncology Congress 2017 | İlker SELÇUK | 114–115 |